These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2901136)

  • 1. [Response of growth hormone to the acute test using GH-releasing factor 1-29 in acromegaly. Comparison in the baseline situation and under treatment with prolonged-action somatostatin].
    Gavilán I; Santos C; García-Luna PP; Acosta D; Leal-Cerro A; Navarro E; Fernández-López I; Astorga R
    Rev Clin Esp; 1988 Mar; 182(4):187-91. PubMed ID: 2901136
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed release formulation of the somatostatin analog RC-160 inhibits the growth hormone (GH) response to GH-releasing factor-(1-29)NH2 and decreases elevated prolactin levels in rats.
    Bokser L; Schally AV
    Endocrinology; 1988 Oct; 123(4):1735-9. PubMed ID: 2901338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone responsiveness to human pancreatic growth hormone releasing factor in acromegaly: modulatory effects of basal hormone levels and of concomitant somatostatin administration.
    Pieters GF; Smals AE; Hermus AR; Smals AG; Benraad TJ; Kloppenborg PW
    Clin Endocrinol (Oxf); 1984 Dec; 21(6):701-7. PubMed ID: 6150772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma insulin-like growth factor-I/somatomedin-C in acromegaly: correlation with the degree of growth hormone hypersecretion.
    Barkan AL; Beitins IZ; Kelch RP
    J Clin Endocrinol Metab; 1988 Jul; 67(1):69-73. PubMed ID: 2897974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acromegaly with the long-acting somatostatin analog SMS 201-995.
    Barkan AL; Kelch RP; Hopwood NJ; Beitins IZ
    J Clin Endocrinol Metab; 1988 Jan; 66(1):16-23. PubMed ID: 2891720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of minisomatostatin on anomalous growth hormone responses in acromegaly.
    Pieters GF; Smals AE; Smals AG; von Gennep JA; Kloppenborg PW
    Acta Endocrinol (Copenh); 1987 Apr; 114(4):537-42. PubMed ID: 2883797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [100 years of acromegaly: general lessons about a rare disease].
    Lamberts SW
    Ned Tijdschr Geneeskd; 1986 May; 130(20):902-4. PubMed ID: 2873513
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical applications of somatostatin analogs.
    Marbach P; Neufeld M; Pless J
    Adv Exp Med Biol; 1985; 188():339-53. PubMed ID: 2863941
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term management of acromegaly with sandostatin.
    Tolis G
    Horm Res; 1988; 29(2-3):112-4. PubMed ID: 2900189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical treatment of acromegaly with SMS 201-995, a somatostatin analog: a comparison with bromocriptine.
    Chiodini PG; Cozzi R; Dallabonzana D; Oppizzi G; Verde G; Petroncini M; Liuzzi A; del Pozo E
    J Clin Endocrinol Metab; 1987 Mar; 64(3):447-53. PubMed ID: 2880861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic use of the GRF test in the study of GH secretion].
    Ramos M; Fernández A; Ferrández A; Mayayo E; Guallar A
    An Esp Pediatr; 1987 Oct; 27(4):269-73. PubMed ID: 2892455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acromegaly.
    Bloom SR
    Am J Med; 1987 May; 82(5B):88-91. PubMed ID: 2884882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly: six-month report on an Italian multicenter study. Italian Multicenter Slow Release Lanreotide Study Group.
    Giusti M; Gussoni G; Cuttica CM; Giordano G
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2089-97. PubMed ID: 8964833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of an acute octreotide suppression test in predicting long-term responses to depot somatostatin analogues in patients with active acromegaly.
    Karavitaki N; Botusan I; Radian S; Coculescu M; Turner HE; Wass JA
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):282-8. PubMed ID: 15730408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
    Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW
    Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of gender and gonadal status on the long-term response to somatostatin analogue treatment in acromegaly.
    Colao A; Pivonello R; Cappabianca P; Briganti F; Tortora F; Auriemma RS; De Martino MC; Marzullo P; Lombardi G
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):342-9. PubMed ID: 16117824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Response of growth hormone to GRF(1-29)NH2 in 12 cases of active acromegaly].
    Santos Español C; Acosta Delgado D; García-Luna P; Navarro González E; Gavilán Villarejo I; Fernández López I; Leal del Cerro A; García de Pesquera F; Astorga Jiménez R
    Rev Clin Esp; 1987 Mar; 180(5):242-6. PubMed ID: 2885902
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetic-pharmacodynamic comparison of a novel multiligand somatostatin analog, SOM230, with octreotide in patients with acromegaly.
    Ma P; Wang Y; van der Hoek J; Nedelman J; Schran H; Tran LL; Lamberts SW
    Clin Pharmacol Ther; 2005 Jul; 78(1):69-80. PubMed ID: 16003295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between somatomedin-C and growth hormone levels in acromegaly: basal and dynamic evaluation.
    Oppizzi G; Petroncini MM; Dallabonzana D; Cozzi R; Verde G; Chiodini PG; Liuzzi A
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1348-53. PubMed ID: 2878007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical management of acromegaly due to ectopic production of growth hormone-releasing hormone by a carcinoid tumor.
    Melmed S; Ziel FH; Braunstein GD; Downs T; Frohman LA
    J Clin Endocrinol Metab; 1988 Aug; 67(2):395-9. PubMed ID: 2899089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.